| EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ... Obesity Facts 9 (2), 65-90, 2016 | 2789 | 2016 |
| EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ... DIABETOLOGIA 59 (6), 1148-9, 2016 | 2778* | 2016 |
| EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ... J Hepatol 64 (6), 1388-402, 2016 | 2778* | 2016 |
| Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration JA Romijn, EF Coyle, LS Sidossis, A Gastaldelli, JF Horowitz, E Endert, ... American Journal of Physiology-Endocrinology And Metabolism 265 (3), E380-E391, 1993 | 2721 | 1993 |
| A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis R Belfort, SA Harrison, K Brown, C Darland, J Finch, J Hardies, B Balas, ... New England Journal of Medicine 355 (22), 2297-2307, 2006 | 2272 | 2006 |
| Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease M Gaggini, M Morelli, E Buzzigoli, RA DeFronzo, E Bugianesi, ... Nutrients 5 (5), 1544-1560, 2013 | 1102 | 2013 |
| Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms E Bugianesi, A Gastaldelli, E Vanni, R Gambino, M Cassader, S Baldi, ... Diabetologia 48, 634-642, 2005 | 1013 | 2005 |
| Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects A Gastaldelli, K Cusi, M Pettiti, J Hardies, Y Miyazaki, R Berria, ... Gastroenterology 133 (2), 496-506, 2007 | 792 | 2007 |
| A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes S Kashyap, R Belfort, A Gastaldelli, T Pratipanawatr, R Berria, ... Diabetes 52 (10), 2461-2474, 2003 | 738 | 2003 |
| β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis E Ferrannini, A Gastaldelli, Y Miyazaki, M Matsuda, A Mari, RA DeFronzo The Journal of Clinical Endocrinology & Metabolism 90 (1), 493-500, 2005 | 700 | 2005 |
| Why does obesity cause diabetes? S Klein, A Gastaldelli, H Yki-Järvinen, PE Scherer Cell metabolism 34 (1), 11-20, 2022 | 574 | 2022 |
| Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity E Bugianesi, U Pagotto, R Manini, E Vanni, A Gastaldelli, R de Iasio, ... The journal of clinical endocrinology & metabolism 90 (6), 3498-3504, 2005 | 558 | 2005 |
| Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis F Marra, A Gastaldelli, GS Baroni, G Tell, C Tiribelli Trends in molecular medicine 14 (2), 72-81, 2008 | 556 | 2008 |
| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis C Saponaro, M Gaggini, F Carli, A Gastaldelli Nutrients 7 (11), 9453-9474, 2015 | 551 | 2015 |
| Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease R Lomonaco, C Ortiz‐Lopez, B Orsak, A Webb, J Hardies, C Darland, ... Hepatology 55 (5), 1389-1397, 2012 | 533 | 2012 |
| Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients E Muscelli, A Mari, A Casolaro, S Camastra, G Seghieri, A Gastaldelli, ... Diabetes 57 (5), 1340-1348, 2008 | 528 | 2008 |
| Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population A Gastaldelli, M Kozakova, K Højlund, A Flyvbjerg, A Favuzzi, A Mitrakou, ... Hepatology 49 (5), 1537-1544, 2009 | 512 | 2009 |
| Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ... Liver International 31 (9), 1285-1297, 2011 | 485 | 2011 |
| Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study A Gastaldelli, E Ferrannini, Y Miyazaki, M Matsuda, RA DeFronzo Diabetologia 47 (1), 31-39, 2004 | 453 | 2004 |
| Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars PK Luukkonen, S Sädevirta, Y Zhou, B Kayser, A Ali, L Ahonen, ... Diabetes care 41 (8), 1732-1739, 2018 | 443 | 2018 |